Title : Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition - Seitz_2009_Anticancer.Drugs_20_553 |
Author(s) : Seitz S , Schally AV , Treszl A , Papadia A , Rick F , Szalontay L , Szepeshazi K , Ortmann O , Halmos G , Hohla F , Buchholz S |
Ref : Anticancer Drugs , 20 :553 , 2009 |
Abstract : |
PubMedSearch : Seitz_2009_Anticancer.Drugs_20_553 |
PubMedID: 19491659 |